CVRx (CVRX) EBITDA Margin (2020 - 2026)

CVRx (CVRX) recorded quarterly EBITDA Margin of 88.83% in Q1 2026, down 19.28% quarter-over-quarter from 74.48% in Q4 2025, and up 2265.0% on a YoY basis from 3.76% in Q1 2025.

CVRx (CVRX) EBITDA Margin (2020 - 2026) Analysis & Trends

CVRx's EBITDA Margin history runs 7 years deep, the most recent figure standing at 88.83% for Q1 2026.

  • In Q1 2026, EBITDA Margin rose 2265.0% year-over-year to 88.83%; the TTM figure through Mar 2026 stood at 89.14% (up 834.0% YoY), while the FY2025 annual figure was 94.09%, up 2282.0% from the prior year.
  • EBITDA Margin was 88.83% for Q1 2026 at CVRx, down from 74.48% in the prior quarter.
  • In the past five years, EBITDA Margin ranged from a high of 69.41% in Q4 2024 to a low of 245.26% in Q1 2022.
  • Historically, EBITDA Margin has averaged 127.42% across 5 years, with a median of 111.48% in 2025.
  • The sharpest annual moves came in 2022 and 2024: EBITDA Margin surged 34814 bps in 2022, then sank 6351 bps in 2024.
  • A 5-year view of EBITDA Margin shows it stood at 146.66% in 2022, then surged by 45 bps to 81.04% in 2023, then climbed by 14 bps to 69.41% in 2024, then dropped by 7 bps to 74.48% in 2025, then decreased by 19 bps to 88.83% in 2026.
  • The last three EBITDA Margin figures came in at 88.83% (Q1 2026), 74.48% (Q4 2025), and 87.62% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 12.05%
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 15.55%
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 16.24%
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 21.16%
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 28.97%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 14.52%
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 21.42%
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 10.04%
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 19.94%
10 CVRx 130.46 Mn 58.16 Mn 12.88 Mn -88.83%

Historic Data

Download Data
DateValue
Mar 31, 2026 -88.83%
Dec 31, 2025 -74.48%
Sep 30, 2025 -87.62%
Jun 30, 2025 -108.42%
Mar 31, 2025 -111.48%
Dec 31, 2024 -69.41%
Sep 30, 2024 -97.94%
Jun 30, 2024 -118.82%
Mar 31, 2024 -206.03%
Dec 31, 2023 -81.04%
Sep 30, 2023 -85.93%
Jun 30, 2023 -122.46%
Mar 31, 2023 -142.51%
Dec 31, 2022 -146.66%
Sep 30, 2022 -159.04%
Jun 30, 2022 -220.19%
Mar 31, 2022 -245.26%
Dec 31, 2021 -288.96%
Sep 30, 2021 -180.74%
Jun 30, 2021 -568.33%